Dear Valued Visitor,

We have noticed that you are using an ad blocker software.

Although advertisements on the web pages may degrade your experience, our business certainly depends on them and we can only keep providing you high-quality research based articles as long as we can display ads on our pages.

To view this article, you can disable your ad blocker and refresh this page or simply login.

We only allow registered users to use ad blockers. You can sign up for free by clicking here or you can login if you are already a member.

Ray Dalio’s 5 Monster Moves in Q1: Disney, McDonald’s, Alphabet, Amazon, Coca-Cola

Page 1 of 2

If the monitoring of the latest hedge fund moves is of any importance to a retail investor (and we believe that it is), then Ray Dalio‘s Bridgewater Associates, the world’s largest hedge fund with more than $150 billion in assets under management, deserves special attention. After a thorough look through the firm’s latest 13F filing, which revealed that it still has several large bets on ETFs, including emerging markets ETFs, we pinpointed the five biggest moves made during the first quarter by the billionaire’s firm. Without further ado, let’s check out five prominent stocks that Mr. Dalio bought or sold during the first quarter.

Today there are dozens of tools investors can use to grade their holdings. A duo of the most under-the-radar tools are hedge fund and insider trading sentiment. Our researchers have shown that, historically, those who follow the top picks of the elite fund managers can trounce their index-focused peers by a very impressive margin (see the details here).

Amazon.com, Inc. (NASDAQ:AMZN)

 – Shares Owned by Bridgewater Associates (as of March 31): 0

 – Value of Holding (as of March 31): 0

Amazon has enjoyed a torrid run since the start of 2015, gaining about 128% in value, which may have prompted Bridgewater to take profits and move on. After trimming its Amazon stake by 57% during the fourth quarter, it sold out of the remaining 8,206 shares during the first quarter. According to The Wall Street Journal, Amazon.com, Inc. (NASDAQ:AMZN) is scheduled to make its first foray into perishable food in the coming weeks, with a range of products including nuts, spices, tea, coffee, baby food, and vitamins. The company seems to have an insatiable appetite to enter as many markets as it can, beyond just being an industry leader in the cloud and e-commerce industries. Alex Snow‘s Lansdowne Partners hiked its stake in Amazon.com, Inc. (NASDAQ:AMZN) by 19% during the March quarter to 2.2 million shares.

Follow Amazon Com Inc (NASDAQ:AMZN)
Trade (NASDAQ:AMZN) Now!

The Coca-Cola Co (NYSE:KO)

 – Shares Owned by Bridgewater Associates (as of March 31): 0

 – Value of Holding (as of March 31): 0

Another holding that Bridgewater wiped from its equity portfolio during the first three months of the year was that of the $194 billion beverage giant. The fund held about 298,000 shares of The Coca-Cola Co (NYSE:KO) at the end of last year. As a consumer staples stock, Coca Cola shares have shown low volatility in the past and according to Barclays’ Jonathan Glionna, are still cheap, whereas other names in the sector continue to climb to higher earnings multiples. In its financial results for the first quarter, The Coca-Cola Co (NYSE:KO) delivered revenue which was in-line with expectations, while earnings exceeded estimates. According to CEO Kent Mukhtar, the company seems to be making good progress on the five-point transition plan that he announced about a year-and-a-half ago, with the goal of reinvigorating growth and increasing profitability. Yacktman Asset Management, which is led by Donald Yacktman, reduced its Coca-Cola holding by 9% during the first quarter to 18.29 million shares.

Follow Coca Cola Co (NYSE:KO)
Trade (NYSE:KO) Now!

On the next page we discuss three major stocks that Mr. Dalio added to his fund’s portfolio in the first quarter.

Page 1 of 2

Biotech Stock Alert - 20% Guaranteed Return in One Year

Hedge Funds and Insiders Are Piling Into

One of 2015's best hedge funds and two insiders snapped up shares of this medical device stock recently. We believe its transformative and disruptive device will storm the $3+ billion market and help it achieve 500%-1000% gains in 3 years.

Get your FREE REPORT and the details of our 20% return guarantee today.

Subscribe me to Insider Monkey's Free Daily Newsletter
This is a FREE report from Insider Monkey. Credit Card is NOT required.
Loading Comments...
X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 102% in 3 years!! Wondering How?

Download a complete edition of our newsletter for free!